Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

INVO Fertility (IVF) Notes Payables (2016 - 2025)

INVO Fertility (IVF) has disclosed Notes Payables for 15 consecutive years, with $149293.0 as the latest value for Q3 2025.

  • On a quarterly basis, Notes Payables fell 98.0% to $149293.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $149293.0, a 98.0% decrease, with the full-year FY2024 number at $5.2 million, up 87.17% from a year prior.
  • Notes Payables was $149293.0 for Q3 2025 at INVO Fertility, down from $2.9 million in the prior quarter.
  • In the past five years, Notes Payables ranged from a high of $7.5 million in Q3 2024 to a low of $149293.0 in Q3 2025.
  • A 5-year average of $2.6 million and a median of $2.7 million in 2023 define the central range for Notes Payables.
  • Peak YoY movement for Notes Payables: surged 262.41% in 2023, then plummeted 98.0% in 2025.
  • INVO Fertility's Notes Payables stood at $453406.0 in 2021, then soared by 68.2% to $762644.0 in 2022, then soared by 262.41% to $2.8 million in 2023, then surged by 87.17% to $5.2 million in 2024, then tumbled by 97.11% to $149293.0 in 2025.
  • Per Business Quant, the three most recent readings for IVF's Notes Payables are $149293.0 (Q3 2025), $2.9 million (Q2 2025), and $6.5 million (Q1 2025).